These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 946902)

  • 1. The chronically reserpinized rat as a possible animal model for cystic fibrosis. IV. The protein composition of pulmonary lavage fluid.
    Thompson FE; Quissell DO; Williams CH; Martinez JR
    Pediatr Res; 1976 Jun; 10(6):632-5. PubMed ID: 946902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chronically reserpinized rat as an animal model for cystic fibrosis: I. Acute effect of isoproterenol and pilocarpine upon pulmonary lavage fluid.
    Mawhinney TP; Feather MS; Martinez JR; Barbero GJ
    Pediatr Res; 1979 Jun; 13(6):760-3. PubMed ID: 481944
    [No Abstract]   [Full Text] [Related]  

  • 3. The chronically reserpinized rat as a possible model for cystic fibrosis. VI. Synergistic effects of isoproterenol on Ca++ and protein in the submaxillary gland.
    Wood DL; Martinez R
    Pediatr Res; 1977 Jul; 11(7):827-32. PubMed ID: 876704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosis.
    Leblond FA; Morisset J; LeBel D
    Pediatr Res; 1989 May; 25(5):478-81. PubMed ID: 2717264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chronically reserpinized rat as a model for cystic fibrosis: alterations in the mucus-secreting sublingual gland.
    Martinez JR; Bylund DB; Mawhinney T; Camden J; Ray G
    Pediatr Res; 1983 Jul; 17(7):523-8. PubMed ID: 6622094
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronically reserpinized rat as a model for cystic fibrosis: Na+ transport inhibitory effect in submaxillary saliva.
    Martinez JR; Martinez AM; Garrett L; Korman P
    Pediatr Res; 1979 Oct; 13(10):1156-9. PubMed ID: 503644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and cystic fibrosis.
    Roomans GM
    Scan Electron Microsc; 1986; (Pt 1):165-78. PubMed ID: 3738414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronically reserpinized rat as a possible model for cystic fibrosis. II. Comparison and cilioinhibitory effects of submaxillary saliva.
    Martinez JR; Adshead PC; Quissell DO; Barbero GJ
    Pediatr Res; 1975 May; 9(5):470-5. PubMed ID: 1134845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.
    Griese M; von Bredow C; Birrer P
    Electrophoresis; 2001 Jan; 22(1):165-71. PubMed ID: 11197168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chronically reserpinized rat as a model for cystic fibrosis: abnormal Cl- transport as the basis for reduced salivary fluid secretion.
    Martinez JR; Cassity N
    Pediatr Res; 1985 Jul; 19(7):711-6. PubMed ID: 4022678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chronically reserpinized rat as a model for cystic fibrosis: alterations in pancreatic enzyme secretion and storage.
    McCurdy RE; Martinez R
    Pediatr Res; 1981 Sep; 15(9):1308-13. PubMed ID: 6170040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis. Carbohydrate metabolism in CF and in animal models for CF.
    Bardoń A
    Acta Paediatr Scand Suppl; 1987; 332():1-30. PubMed ID: 3474861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential fatty acid deficient rats in the study of cystic fibrosis: an X-ray microanalytical and ultrastructural study in chronically reserpinized rats.
    Hjelte L; Strandvik B; Müller RM; Sagström S; Roomans GM
    J Submicrosc Cytol Pathol; 1990 Jul; 22(3):409-14. PubMed ID: 2390763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
    Weizman Z
    Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chronically reserpinized rat as a possible model for cystic fibrosis. VII. Alterations in the secretory response to cholecystokinin and to secretin from the pancreas in vivo.
    Perlmutter J; Martinez JR
    Pediatr Res; 1978 Mar; 12(3):188-94. PubMed ID: 643388
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological and histochemical changes in intestinal mucosa in the reserpine-treated rat model of cystic fibrosis.
    Park CM; Reid PE; Owen DA; Sanker JM; Applegarth DA
    Exp Mol Pathol; 1987 Aug; 47(1):1-12. PubMed ID: 3609243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
    Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
    J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke.
    Subramaniam S; Whitsett JA; Hull W; Gairola CG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):274-80. PubMed ID: 8887443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
    Meyer KC; Cardoni A; Xiang ZZ
    J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.